Survival effect of lung transplantation among patients with cystic fibrosis

JAMA

Volumn 286, Issue 21, 2001, Pages 2683-2689

  Liou, Theodore G ^a   Marshall, Bruce C ^a,a,d   Adler, Frederick R ^b   Cahill, Barbara C ^b   FitzSimmons, Stacey C ^c   Huang, David ^e   Hibbs, Jonathan R ^f  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c Cystic Fibrosis Foundation   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; HUMAN; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; ORGAN DONOR; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME;

EID: 0035814353     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.286.21.2683     Document Type: Article

References (30)

1. Bilateral lung transplantation for cystic fibrosis
2. Improved results of lung transplantation for patients with cystic fibrosis
3. Living-donor lobar lung transplantation experience
4. The actual and potential supply of organ donors in the United States
5. Effect of diagnosis on survival benefit of lung transplantation for end-stage lung disease
6. Prediction of mortality in patients with cystic fibrosis
7. Lung transplantation in cystic fibrosis
8. International guidelines for the selection of lung transplant candidates
9. Risk of death in cystic fibrosis patients with severely compromised lung function
10. Timing of referral for lung transplantation for cystic fibrosis
11. Predictive 5-year survivorship model of cystic fibrosis
12. A prognostic model for the prediction of survival in cystic fibrosis
13. Prognosis of patients with cystic fibrosis awaiting heart and lung transplantation
14. A new prognostic score and clinical evaluation system for cystic fibrosis
15. Clinical features, survival rate, and prognostic factors in young adults with cystic fibrosis
16. Spirometric reference values from a sample of the general U.S. population
17. Physical growth: National Center for Health Statistics percentiles
18. Development of normalized curves for the international growth reference
19. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data
20. FEV(1) as a guide to lung transplant referral in young patients with cystic fibrosis
21. Synthetic retrospective studies and related topics
22. Avoidance of bias in cohort studies
23. Statistical aspects of the analysis of data from retrospective studies of disease
24. Design and analysis of randomized clinical trials requiring prolonged observation of each patient, I: Introduction and design
25. Translation and linguistic validation of a disease-specific quality of life measure for cystic fibrosis
26. Lung transplantation and cystic fibrosis